| Sanjiv K. Patel, M.D. | President and Chief Executive Officer | FY2025 | |
| Donald Bergstrom, M.D., Ph.D. | President, Research & Development | FY2025 | |
| Thomas Catinazzo | Chief Financial Officer | FY2025 | |
| Peter Rahmer | Chief Corporate Development Officer | FY2025 | |
| Brian R. Adams | Former Chief Legal Officer | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.